The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment

被引：4

作者：

Gaebel, Wolfgang ^{[1
,2
]}

Stricker, Johannes ^{[1
,2
]}

Hasan, Alkomiet ^{[3
]}

Falkai, Peter ^{[4
]}

McIntyre, John S. ^{[5
]}

Kerst, Ariane ^{[1
,2
]}

机构：

[1] Heinrich Heine Univ, LVR Klinikum Dusseldorf, Med Fac, Dept Psychiat & Psychotherapy, Dusseldorf, Germany

[2] WHO Collaborating Ctr Qual Assurance & Empowermen, Dusseldorf, Germany

[3] Univ Augsburg, Med Fac, Bezirkskrankenhaus Augsburg, Dept Psychiat Psychotherapy & Psychosomat, Augsburg, Germany

[4] Univ Hosp LMU Munich, Dept Psychiat & Psychotherapy, Munich, Germany

[5] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA

来源：

SCHIZOPHRENIA RESEARCH | 2021年 / 229卷

关键词：

Antipsychotic; Guideline; Long-term; Maintenance; Quality; Schizophrenia;

D O I：

10.1016/j.schres.2020.11.011

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

[No abstract available]

引用

页码：137 / 139

页数：3

共 50 条

[41] The relevance of relapse prevention in the long term treatment of schizophrenia: efficay and effectiveness issues of antipsychotic therapy [J].

Vita, Antonio ;

De Peri, Luca .

RIVISTA DI PSICHIATRIA, 2007, 42 (02) :79-86

[42] Association between pharmacological guideline adherence and actigraphy-measured sleep variables in long-term hospitalized patients with schizophrenia [J].

Saito, Kentaro ;

Arai, Yusuke ;

Sasayama, Daimei ;

Nakamura, Toshinori ;

Suzuki, Kazuhiro ;

Koido, Mika ;

Sahara, Reiko ;

Nakajima, Yuka ;

Horiuchi, Aya ;

Fukui, Fumiya ;

Kuraishi, Kazuaki ;

Washizuka, Shinsuke .

PSYCHIATRY AND CLINICAL NEUROSCIENCES REPORTS, 2025, 4 (03)

[43] An Assessment of the Impact of Prior Antipsychotic Treatment on the Duration of Treatment With RBP-7000 During a Long-Term Safety Study [J].

Le Moigne, Anne ;

Andorn, Anne ;

Graham, James ;

Csernansky, John ;

Newcomer, John ;

Fava, Maurizio .

NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) :163-163

[44] The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review [J].

Thornton, Allen E. ;

Van Snellenberg, Jared X. ;

Sepehry, Amir A. ;

Honer, William G. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2006, 20 (03) :335-346

[45] Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis [J].

Vermeulen, J. ;

van Rooijen, G. ;

Doedens, P. ;

Numminen, E. ;

van Tricht, M. ;

de Haan, L. .

PSYCHOLOGICAL MEDICINE, 2017, 47 (13) :2217-2228

[46] Should Antipsychotic Medications for Schizophrenia Be Given for a Lifetime?: A Naturalistic, Long-Term Follow-Up Study [J].

Glick, Ira D. ;

Davis, John M. ;

Zamora, Daisy ;

Ballon, Jacob ;

Nuthi, Meena .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (02) :125-130

[47] Antipsychotic-associated neuronal changes in the brain: Toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia? [J].

Dean, CE .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (02) :174-189

[48] Amisulpride: A safe and effective option for the long-term treatment of patients with schizophrenia [J].

Naber, D ;

Arlt, J ;

Lambert, M .

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (03) :167-175

[49] Medical care and long-term treatment of patients with schizophrenia: ethical concerns [J].

Frederico Simões do Couto .

Annals of General Psychiatry, 9 (Suppl 1)

[50] Long-Term Safety for Lumateperone (ITI-007) in the Treatment of Schizophrenia [J].

Vanover, Kimberly ;

Correll, Christoph ;

Weingart, Michal ;

Saillard, Jelena ;

Hossain, Shawn ;

Glass, Steven ;

Kozauer, Susan ;

Satlin, Andrew ;

Davis, Robert .

NEUROPSYCHOPHARMACOLOGY, 2018, 43 :S328-S329

← 1 2 3 4 5 →